IFN-alpha and novel strategies of combination therapy for cancer (Q36849152)

16 August 2017

1 reference

title

IFN-alpha and novel strategies of combination therapy for cancer (English)

1 reference

16 August 2017

Laura Bracci

1 reference

16 August 2017

Enrico Proietti

series ordinal

1 reference

16 August 2017

Filippo Belardelli

series ordinal

1 reference

16 August 2017

language of work or name

English

0 references

publication date

13 June 2007

1 reference

Annals of the New York Academy of Sciences

16 August 2017

published in

1 reference

16 August 2017

volume

1112

1 reference

16 August 2017

page(s)

256-268

1 reference

Interferon-alpha in tumor immunity and immunotherapy

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Type I interferon-mediated stimulation of T cells by CpG DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Origin, maturation and antigen presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.030

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1415.030

1 reference

16 August 2017

1 reference